Search research articles
Contact Us
Filters
Showing results (21-30 of 238) with videos related to
Page
of 24
Sort By:
Blood Cells, Molecules & Diseases
|
June 15, 2010
Nonprecipitous changes upon withdrawal from imiglucerase for Gaucher disease because of a shortage in supply
Ari Zimran, Gheona Altarescu, Deborah Elstein
Blood Cells, Molecules & Diseases
|
October 23, 2012
Pilot study using ambroxol as a pharmacological chaperone in type 1 Gaucher disease
Ari Zimran, Gheona Altarescu, Deborah Elstein
American Journal of Hematology
|
June 23, 2015
Gaucher disease types 1 and 3: Phenotypic characterization of large populations from the ICGG Gaucher Registry
Gregory A Grabowski, Ari Zimran, Hiroyuki Ida
Expert Review of Hematology
|
March 24, 2021
Hematological manifestations and complications of Gaucher disease
Shoshana Revel-Vilk, Jeff Szer, Ari Zimran
Hematology. American Society of Hematology. Education Program
|
December 4, 2020
A patient with Gaucher disease and plasma cell dyscrasia: bidirectional impact
Ari Zimran, Rosa Ruchlemer, Shoshana Revel-Vilk
Internal Medicine Journal
|
July 14, 2020
Impact of Gaucher disease on COVID-19
Ari Zimran, Jeff Szer, Shoshana Revel-Vilk
International Journal of Molecular Sciences
|
October 1, 2020
Value of Glucosylsphingosine (Lyso-Gb1) as a Biomarker in Gaucher Disease: A Systematic Literature Review
Shoshana Revel-Vilk, Maria Fuller, Ari Zimran
Acta Haematologica
|
August 21, 2002
Thrombocytosis associated with enzyme replacement therapy in Gaucher disease
Altoon Dweck, Dorit Blickstein, Deborah Elstein, et al.
Cytokine
|
May 28, 2005
TNF-alpha levels and TNF-alpha gene polymorphism in type I Gaucher disease
Gheona Altarescu, Ari Zimran, Helen Michelakakis, et al.
Blood Cells, Molecules & Diseases
|
November 16, 2016
Liver involvement in Gaucher disease - Review and clinical approach
Tomer Adar, Yaron Ilan, Deborah Elstein, et al.
Page
of 24
Search research articles
Search
Showing results (21-30 of 238) with videos related to
Sort By:
Page
of 24
Blood Cells, Molecules & Diseases
|
June 15, 2010
Nonprecipitous changes upon withdrawal from imiglucerase for Gaucher disease because of a shortage in supply
Ari Zimran, Gheona Altarescu, Deborah Elstein
Blood Cells, Molecules & Diseases
|
October 23, 2012
Pilot study using ambroxol as a pharmacological chaperone in type 1 Gaucher disease
Ari Zimran, Gheona Altarescu, Deborah Elstein
American Journal of Hematology
|
June 23, 2015
Gaucher disease types 1 and 3: Phenotypic characterization of large populations from the ICGG Gaucher Registry
Gregory A Grabowski, Ari Zimran, Hiroyuki Ida
Expert Review of Hematology
|
March 24, 2021
Hematological manifestations and complications of Gaucher disease
Shoshana Revel-Vilk, Jeff Szer, Ari Zimran
Hematology. American Society of Hematology. Education Program
|
December 4, 2020
A patient with Gaucher disease and plasma cell dyscrasia: bidirectional impact
Ari Zimran, Rosa Ruchlemer, Shoshana Revel-Vilk
Internal Medicine Journal
|
July 14, 2020
Impact of Gaucher disease on COVID-19
Ari Zimran, Jeff Szer, Shoshana Revel-Vilk
International Journal of Molecular Sciences
|
October 1, 2020
Value of Glucosylsphingosine (Lyso-Gb1) as a Biomarker in Gaucher Disease: A Systematic Literature Review
Shoshana Revel-Vilk, Maria Fuller, Ari Zimran
Acta Haematologica
|
August 21, 2002
Thrombocytosis associated with enzyme replacement therapy in Gaucher disease
Altoon Dweck, Dorit Blickstein, Deborah Elstein, et al.
Cytokine
|
May 28, 2005
TNF-alpha levels and TNF-alpha gene polymorphism in type I Gaucher disease
Gheona Altarescu, Ari Zimran, Helen Michelakakis, et al.
Blood Cells, Molecules & Diseases
|
November 16, 2016
Liver involvement in Gaucher disease - Review and clinical approach
Tomer Adar, Yaron Ilan, Deborah Elstein, et al.
Page
of 24